Adaptive Biotechnologies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

MUN:1HM Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 May 25	Sell€15,388	Kyle Piskel	Individual	1,929	€7.98
13 Mar 25	Sell€240,188	Michelle Griffin	Individual	36,291	€6.62
12 Mar 25	Sell€368,479	Robert Hershberg	Individual	53,000	€6.95
06 Mar 25	Sell€1,477,825	Chad Robins	Individual	219,569	€7.05
05 Mar 25	Sell€626,671	Harlan Robins	Individual	96,656	€6.49
05 Mar 25	Sell€385,662	Julie Rubinstein	Individual	59,505	€6.49
05 Mar 25	Sell€66,890	Kyle Piskel	Individual	10,320	€6.49
05 Mar 25	Sell€289,374	Sharon Benzeno	Individual	44,665	€6.49
05 Mar 25	Sell€168,581	Susan Bobulsky	Individual	26,023	€6.48
05 Mar 25	Sell€135,359	Francis Lo	Individual	20,875	€6.49
18 Nov 24	Sell€1,168	Kyle Piskel	Individual	248	€4.71

Insider Trading Volume

Insider Buying: 1HM insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1HM?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	7,511,658	4.92%
Hedge Funds	44,593,708	29.2%
Institutions	100,488,921	65.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.2%	Viking Global Investors LP	29,993,708	€206.8m	0%	0.82%
9.83%	Rubric Capital Management LP	14,600,000	€100.7m	1.39%	2.48%
8.16%	BlackRock, Inc.	12,120,846	€83.6m	1.58%	no data
7.21%	The Vanguard Group, Inc.	10,714,888	€73.9m	0.71%	no data
6.34%	ARK Investment Management LLC	9,424,074	€65.0m	-18.8%	0.72%
4.6%	Nikko Asset Management Co., Ltd.	6,833,137	€47.1m	-11.7%	0.02%
4.6%	Sumitomo Mitsui Trust Asset Management Co., Ltd.	6,833,137	€47.1m	-11.7%	0.04%
4.24%	Millennium Management LLC	6,292,634	€43.4m	-33.1%	0.05%
2.27%	Massachusetts Financial Services Company	3,370,919	€23.2m	17%	0.01%
2.01%	Soleus Capital Management, L.P.	2,983,142	€20.6m	168%	1.75%
1.99%	Chad Robins	2,959,249	€20.4m	63%	no data
1.94%	Aristotle Atlantic Partners, LLC	2,886,702	€19.9m	-3.82%	0.62%
1.84%	State Street Global Advisors, Inc.	2,729,901	€18.8m	6.98%	no data
1.81%	Geode Capital Management, LLC	2,684,506	€18.5m	0.85%	no data
1.63%	Voya Investment Management LLC	2,428,710	€16.7m	6,120%	0.02%
1.44%	Blue Water Life Science Advisors, LP	2,145,145	€14.8m	0%	14.98%
1.08%	Dimensional Fund Advisors LP	1,604,876	€11.1m	12.9%	no data
0.89%	Goldman Sachs Asset Management, L.P.	1,328,308	€9.2m	-3.43%	no data
0.86%	Harlan Robins	1,279,524	€8.8m	25.3%	no data
0.86%	Pier Capital, LLC	1,274,293	€8.8m	-0.12%	1.74%
0.84%	Point72 Asset Management, L.P.	1,254,951	€8.7m	54.1%	0.02%
0.74%	Northern Trust Global Investments	1,093,981	€7.5m	13.5%	no data
0.68%	Aberdeen Group Plc	1,004,059	€6.9m	-2.47%	0.01%
0.64%	Charles Schwab Investment Management, Inc.	956,574	€6.6m	0%	no data
0.61%	Goldman Sachs Group, Investment Banking and Securities Investments	909,818	€6.3m	143%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/15 01:05
End of Day Share Price	2025/01/16 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Adaptive Biotechnologies Corporation is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Derik de Bruin	BofA Global Research
Mark Massaro	BTIG
Daniel Leonard	Credit Suisse